[HTML][HTML] Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon

CI Penda, M Moukoko Mbonjo, J Fokam, ABD Djeuda… - PLoS …, 2022 - journals.plos.org
The objective of this study was to determine the rates of virological failure (VF) and HIV drug
resistance (HIVDR) amongst adolescents on antiretroviral Therapy (ART). A retrospectively …

High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World …

K Kebe, M Thiam, NR Diagne Gueye… - AIDS research and …, 2013 - liebertpub.com
The rates of virological failure (VF) and HIV-1 drug resistance were evaluated in a cross-
sectional study in HIV-1-infected children living in Dakar, and taking antiretroviral treatment …

[HTML][HTML] Viral monitoring and prevalence of viral failure in HIV-1 infected children under first line antiretroviral therapy during the first 60 months of treatment in …

AEN Nlend, S Lyeb, STN Moyo, AN Motaze - Open Journal of Pediatrics, 2016 - scirp.org
Objective: The objective was to measure the prevalence of viral failure (VF) in HIV-1-infected
children on first-line antiretroviral therapy (ART) in routine practice. Methods: Serial cross …

[HTML][HTML] High risk of virologic failure among HIV-infected children and adolescents routinely followed-up in Littoral region of Cameroon

PJ Mbébi Enoné, CI Penda, G Ngondi, J Fokam… - Plos one, 2023 - journals.plos.org
Virological response to antiretroviral therapy (ART) remains a challenge for HIV-infected
children and adolescents due to non-optimization of pediatric ART for resource-limited …

[HTML][HTML] Prevalence and characteristics of HIV drug resistance among antiretroviral treatment (ART) experienced adolescents and young adults living with HIV in …

S Miti, R Handema, L Mulenga, JK Mwansa… - PLoS …, 2020 - journals.plos.org
Background HIV drug resistance (HIVDR) poses a threat to the HIV epidemic control in
Zambia especially in sub-populations such as the 15–24 years where there is poor …

Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study

A Zoufaly, Q Fillekes, R Hammerl, N Nassimi… - Antiviral …, 2013 - journals.sagepub.com
Background In Africa, success of antiretroviral treatment (ART) seems to lag behind in
children compared with adults, and high therapeutic failure rates have been reported. We …

[HTML][HTML] HIV-1 Disease Progression and Drug Resistance Mutations among Children on First-Line Antiretroviral Therapy in Ethiopia

Y Getaneh, F Getnet, F Ning, A Rashid, L Liao, F Yi… - Biomedicines, 2023 - mdpi.com
Background: High rates of disease progression and HIV drug resistance (HIVDR) among
adults taking highly active antiretroviral treatment (HAART) in Sub-Saharan Africa were …

[HTML][HTML] Incidence and predictors of virological failure among HIV infected children and adolescents on first-line antiretroviral therapy in East Shewa hospitals, Oromia …

NM Abera, TG Alemu, CD Agegnehu - Plos one, 2023 - journals.plos.org
Introduction Despite gains made from improved antiretroviral therapy coverage in resource
limited countries, the occurrence of first line drug resistance remains a priority agenda. To …

Virological response and resistances over 12 months among HIV‐infected children less than two years receiving first‐line lopinavir/ritonavir‐based antiretroviral …

C Amani‐Bosse, DL Dahourou… - Journal of the …, 2017 - Wiley Online Library
Introduction: Lopinavir/ritonavir‐based antiretroviral therapy (ART) is recommended for all
HIV‐infected children less than three years. However, little is known about its field …

[HTML][HTML] High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st …

CD Mossoro-Kpinde, JC Gody, RSM Bouassa… - Medicine, 2017 - journals.lww.com
A large cohort of 220 HIV-1-infected children (median [range] age: 12 [4–17] years) was
cared and followed up in the Central African Republic, including 198 in 1st-line and 22 in …